
February 2, 2015
Dear Friends,
Drugs that can cure hepatitis C virus (HCV) are on the market in some
countries. But these drugs are unaffordable for most of the 150 million
people living with hepatitis C globally --90% of whom live in
resource-limited settings. Activism to overcome pricing and other
barriers to treatment is urgently needed.
TAG is pleased to release
Activist Strategies for Increasing Access to HCV Treatment in Low- and Middle-Income Countries.
This guide presents key strategies through real-world case studies, and
shows how strategies used to combat the AIDS epidemic can be—and have
been—adapted to increase HCV treatment access.
We hope you find this document useful in your global treatment advocacy work. Please share widely with relevant stakeholders.